NCT03912155 Multi-scale Analysis of Physiological Brain Networks
| NCT ID | NCT03912155 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique Hopitaux De Marseille |
| Condition | Epilepsy |
| Study Type | OBSERVATIONAL |
| Enrollment | 240 participants |
| Start Date | 2019-04-15 |
| Primary Completion | 2025-04-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 240 participants in total. It began in 2019-04-15 with a primary completion date of 2025-04-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The SEEG implantation is performed on purely clinical criteria for preoperative diagnosis. Magnetoencephalography and EEG are purely passive techniques that do not involve any additional risk. This project is a continuation of an existing project in which it was demonstrated the feasibility of simultaneous SEEG and MEG/EEG recordings.
Eligibility Criteria
Inclusion Criteria: * Inclusion criteria for patients * Patients for whom intracerebral electrode implantation is in progress as part of the pre-surgical evaluation of their drug-resistant partial epilepsy. * Patient informed, expressing his non-opposition (or legal representative (s), affiliated to a social security scheme * The medical examination is carried out as part of the medical follow-up of these patients * Inclusion criteria for control subjects • Informed subject, expressing his non-opposition or legal representative, affiliated to a social security scheme * Exclusion Criteria: Minors under 12 years * Pregnant or lactating women, * The adults under guardianship or under the protection of justice * Non-beneficiaries of a social security scheme * Persons deprived of their liberty by a judicial or administrative decision * Absence of informed consent
Contact & Investigator
Jean-Olivier ARNAUD, Director
STUDY DIRECTOR
Assistance Publique Hôpitaux de Marseille
Frequently Asked Questions
Who can join the NCT03912155 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03912155 currently recruiting?
Yes, NCT03912155 is actively recruiting participants. Contact the research team at fabrice.bartolomei@ap-hm.fr for enrollment information.
Where is the NCT03912155 trial being conducted?
This trial is being conducted at Marseille, France.
Who is sponsoring the NCT03912155 clinical trial?
NCT03912155 is sponsored by Assistance Publique Hopitaux De Marseille. The principal investigator is Jean-Olivier ARNAUD, Director at Assistance Publique Hôpitaux de Marseille. The trial plans to enroll 240 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.